![Nicholas Haft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Haft
Fondateur chez
Delix Therapeutics, Inc.
Profil
Nicholas Haft is the founder of Delix Therapeutics, Inc. Mr. Haft is currently the Director at Arcos Ventures SPV LLC since 2015.
Formerly, Mr. Haft was an Independent Director at Finch Therapeutics Group, Inc. from 2020 to 2023.
Mr. Haft completed undergraduate education at The Wharton School of the University of Pennsylvania.
Postes actifs de Nicholas Haft
| Sociétés | Poste | Début |
|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Fondateur | - |
Arcos Ventures SPV LLC | Directeur Général | 01/04/2015 |
Anciens postes connus de Nicholas Haft
| Sociétés | Poste | Fin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur/Membre du Conseil | 23/06/2023 |
Formation de Nicholas Haft
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Arcos Ventures SPV LLC | |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Health Technology |
